TOBIN JAMES R 4

What Happened
James R. Tobin, a director of Globus Medical (GMED), was granted a derivative award covering 15,000 shares on January 21, 2026. The Form 4 reports the grant at $0.00 per share (no cash paid on grant) and does not show any immediate sale or exercise — this is a typical equity award rather than an open-market purchase or sale.

Key Details

• Transaction date: January 21, 2026 (Filed January 23, 2026; filing appears timely within the required two-business-day window).
• Transaction type/code: Award/Grant (Form 4 code "A") — 15,000 derivative shares reported at $0.00.
• Vesting: Per footnote, these options were granted Jan 21, 2026 and will vest on Jan 1, 2027.
• Shares owned after transaction: Not specified in the provided filing.
• Notable footnote: F1 confirms these are options with a vesting date; no 10b5-1 plan, tax withholding, or cashless exercise noted in the filing.

Context
This filing records an option grant (a retention/compensation award) rather than a purchase or sale; there were no proceeds or immediate share sales reported. Option grants are commonly used to align executives and directors with shareholder interests over time; the award only delivers shares or value if and when the options vest and (if applicable) are exercised according to plan terms.